Annual CFI
$38.90 M
+$300.21 M+114.89%
31 December 2023
Summary:
Fulgent Genetics annual cash flow from investing activities is currently $38.90 million, with the most recent change of +$300.21 million (+114.89%) on 31 December 2023. During the last 3 years, it has risen by +$365.34 million (+111.92%). FLGT annual CFI is now at all-time high.FLGT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$8.98 M
+$1.68 M+23.01%
30 September 2024
Summary:
Fulgent Genetics quarterly cash flow from investing activities is currently $8.98 million, with the most recent change of +$1.68 million (+23.01%) on 30 September 2024. Over the past year, it has dropped by -$11.09 million (-55.25%). FLGT quarterly CFI is now -79.71% below its all-time high of $44.29 million, reached on 30 September 2022.FLGT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$6.63 M
-$11.09 M-248.39%
30 September 2024
Summary:
Fulgent Genetics TTM cash flow from investing activities is currently -$6.63 million, with the most recent change of -$11.09 million (-248.39%) on 30 September 2024. Over the past year, it has increased by +$71.34 million (+91.50%). FLGT TTM CFI is now -117.04% below its all-time high of $38.90 million, reached on 31 December 2023.FLGT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +114.9% | -55.3% | +91.5% |
| 3 y3 years | +111.9% | +125.8% | +99.1% |
| 5 y5 years | +3994.5% | +41.6% | -247.4% |
FLGT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +107.1% | -79.7% | +104.2% | -117.0% | +99.1% |
| 5 y | 5 years | at high | +107.1% | -79.7% | +102.8% | -117.0% | +99.1% |
| alltime | all time | at high | +107.1% | -79.7% | +102.8% | -117.0% | +99.1% |
Fulgent Genetics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $8.98 M(+23.0%) | -$6.63 M(-248.4%) |
| June 2024 | - | $7.30 M(-115.5%) | $4.47 M(-213.5%) |
| Mar 2024 | - | -$47.19 M(-294.4%) | -$3.93 M(-110.1%) |
| Dec 2023 | $38.90 M(-114.9%) | $24.27 M(+20.9%) | $38.90 M(-149.9%) |
| Sept 2023 | - | $20.08 M(-1931.9%) | -$77.97 M(+45.0%) |
| June 2023 | - | -$1.10 M(-74.8%) | -$53.76 M(-79.8%) |
| Mar 2023 | - | -$4.35 M(-95.3%) | -$266.36 M(+1.9%) |
| Dec 2022 | -$261.31 M(-52.2%) | -$92.60 M(-309.1%) | -$261.31 M(-15.4%) |
| Sept 2022 | - | $44.29 M(-120.7%) | -$308.97 M(-20.4%) |
| June 2022 | - | -$213.69 M(<-9900.0%) | -$388.06 M(+17.8%) |
| Mar 2022 | - | $688.00 K(-100.5%) | -$329.37 M(-39.7%) |
| Dec 2021 | -$546.55 M(+67.4%) | -$140.26 M(+303.1%) | -$546.55 M(-24.6%) |
| Sept 2021 | - | -$34.79 M(-77.6%) | -$725.06 M(+4.8%) |
| June 2021 | - | -$155.00 M(-28.4%) | -$691.67 M(+28.3%) |
| Mar 2021 | - | -$216.49 M(-32.1%) | -$539.07 M(+65.1%) |
| Dec 2020 | -$326.44 M | -$318.77 M(>+9900.0%) | -$326.44 M(+646.1%) |
| Sept 2020 | - | -$1.40 M(-41.6%) | -$43.75 M(+21.5%) |
| June 2020 | - | -$2.40 M(-37.7%) | -$36.00 M(+18.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$3.86 M(-89.3%) | -$30.39 M(+4.6%) |
| Dec 2019 | -$29.05 M(-3157.5%) | -$36.08 M(-668.7%) | -$29.05 M(-745.9%) |
| Sept 2019 | - | $6.34 M(+97.6%) | $4.50 M(+44.4%) |
| June 2019 | - | $3.21 M(-227.3%) | $3.12 M(-291.9%) |
| Mar 2019 | - | -$2.52 M(-0.6%) | -$1.62 M(-270.8%) |
| Dec 2018 | $950.00 K(-146.4%) | -$2.54 M(-151.1%) | $950.00 K(-44.9%) |
| Sept 2018 | - | $4.96 M(-425.0%) | $1.72 M(-129.7%) |
| June 2018 | - | -$1.53 M(-3094.1%) | -$5.81 M(+4436.7%) |
| Mar 2018 | - | $51.00 K(-102.9%) | -$128.00 K(-93.8%) |
| Dec 2017 | -$2.05 M(-95.2%) | -$1.76 M(-31.3%) | -$2.05 M(-94.8%) |
| Sept 2017 | - | -$2.57 M(-161.8%) | -$39.70 M(-0.6%) |
| June 2017 | - | $4.15 M(-322.0%) | -$39.95 M(-10.2%) |
| Mar 2017 | - | -$1.87 M(-95.3%) | -$44.49 M(+4.0%) |
| Dec 2016 | -$42.80 M(+1840.8%) | -$39.42 M(+1299.7%) | -$42.80 M(+1166.5%) |
| Sept 2016 | - | -$2.82 M(+629.5%) | -$3.38 M(+500.2%) |
| June 2016 | - | -$386.00 K(+118.1%) | -$563.00 K(+218.1%) |
| Mar 2016 | - | -$177.00 K | -$177.00 K |
| Dec 2015 | -$2.21 M(+182.7%) | - | - |
| Dec 2014 | -$780.00 K | - | - |
FAQ
- What is Fulgent Genetics annual cash flow from investing activities?
- What is the all time high annual CFI for Fulgent Genetics?
- What is Fulgent Genetics annual CFI year-on-year change?
- What is Fulgent Genetics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Fulgent Genetics?
- What is Fulgent Genetics quarterly CFI year-on-year change?
- What is Fulgent Genetics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Fulgent Genetics?
- What is Fulgent Genetics TTM CFI year-on-year change?
What is Fulgent Genetics annual cash flow from investing activities?
The current annual CFI of FLGT is $38.90 M
What is the all time high annual CFI for Fulgent Genetics?
Fulgent Genetics all-time high annual cash flow from investing activities is $38.90 M
What is Fulgent Genetics annual CFI year-on-year change?
Over the past year, FLGT annual cash flow from investing activities has changed by +$300.21 M (+114.89%)
What is Fulgent Genetics quarterly cash flow from investing activities?
The current quarterly CFI of FLGT is $8.98 M
What is the all time high quarterly CFI for Fulgent Genetics?
Fulgent Genetics all-time high quarterly cash flow from investing activities is $44.29 M
What is Fulgent Genetics quarterly CFI year-on-year change?
Over the past year, FLGT quarterly cash flow from investing activities has changed by -$11.09 M (-55.25%)
What is Fulgent Genetics TTM cash flow from investing activities?
The current TTM CFI of FLGT is -$6.63 M
What is the all time high TTM CFI for Fulgent Genetics?
Fulgent Genetics all-time high TTM cash flow from investing activities is $38.90 M
What is Fulgent Genetics TTM CFI year-on-year change?
Over the past year, FLGT TTM cash flow from investing activities has changed by +$71.34 M (+91.50%)